Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism. Read more about Crystal structure and interaction studies of human DHTKD1 provide insight into a mitochondrial megacomplex in lysine catabolism.
Dataset Augmentation Allows Deep Learning-Based Virtual Screening To Better Generalize To Unseen Target Classes, And Highlight Important Binding Interactions. Read more about Dataset Augmentation Allows Deep Learning-Based Virtual Screening To Better Generalize To Unseen Target Classes, And Highlight Important Binding Interactions.
Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants. Read more about Early-infantile onset epilepsy and developmental delay caused by bi-allelic GAD1 variants.
Synergistic drug combinations and machine learning for drug repurposing in chordoma. Read more about Synergistic drug combinations and machine learning for drug repurposing in chordoma.
LOTUS domain is a novel class of G-rich and G-quadruplex RNA binding domain. Read more about LOTUS domain is a novel class of G-rich and G-quadruplex RNA binding domain.
Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1. Read more about Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1.
Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities. Read more about Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities.
DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity. Read more about DFG-1 residue controls inhibitor binding mode and affinity providing a basis for rational design of kinase inhibitor selectivity.
Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma. Read more about Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma.
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways. Read more about A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.
